This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Contrafect Corporation. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: **The Innovative Contributions of Inventor Brent Schneider**
Introduction
Brent Schneider, a dedicated inventor based in Glenmoore, Pennsylvania, has made significant strides in the field of microbiology. With a total of two patents to his name, his work focuses on innovative approaches to combat gram-positive bacterial infections. His contributions, particularly in antibiotic and bacteriophage lysin combinations, highlight his commitment to improving health outcomes through scientific innovation.
Latest Patents
Brent Schneider's most recent patents revolve around the development of compositions and methods aimed at the prevention, amelioration, and treatment of infections caused by gram-positive bacteria. His inventions include:
1. **Bacteriophage lysin and antibiotic combinations against gram-positive bacteria** - This invention specifically addresses Streptococcal infections, utilizing combinations of lysin, particularly PlySs2, along with antibiotics such as daptomycin, vancomycin, and linezolid.
2. **Bacteriophage lysin and antibiotic combinations against gram-positive bacteria** - Similar to the first, this patent focuses on Staphylococcal bacteria and incorporates the same effective combinations of lysin and antibiotics to enhance treatment efficacy.
Career Highlights
Brent Schneider is an influential figure at Contrafect Corporation, where he plays a crucial role in innovating new solutions for bacterial infections. His research not only contributes to the development of new therapies but also reinforces the importance of collaboration in scientific advancements. Schneider's expertise and persistence in research are evident through his impactful inventions.
Collaborations
In his work at Contrafect Corporation, Brent collaborates with esteemed colleagues, including Raymond Schuch and Robert C. Nowinski. Together, this team leverages their collective expertise to drive forward projects that aim to transform how bacterial infections are managed and treated across various healthcare settings.
Conclusion
Brent Schneider's innovative spirit and dedication to fighting bacterial infections through his patented inventions have positioned him as a noteworthy inventor in the field of microbiology. His contributions, particularly in the realm of bacteriophage lysins and antibiotic combinations, stand to make a significant impact on public health, showcasing the essential role that inventors play in advancing medical science.